WHO Approves Cecolin® for Single-Dose HPV Vaccination in Fight Against Cervical Cancer

The World Health Organization (WHO) has recently prequalified Cecolin®, a Human Papillomavirus (HPV) vaccine, for use in a single-dose regimen to help prevent cervical cancer. This marks a significant step forward in the global fight against the disease, which continues to affect hundreds of thousands of women each year, particularly in low- and middle-income countries….